CIC
AMED

Cornercap Investment Counsel’s Amedisys AMED Stock Holding History

Cornercap Investment Counsel’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,240
Closed -$1.12M – 392
2019
Q2 		$1.12M Sell
9,240
-100
-1% -$11.9K 0.15% 206
2019
Q1 		$1.15M Buy
9,340
+1,770
+23% +$222K 0.16% 175
2018
Q4 		$887K Buy
+7,570
New +$892K 0.14% 242

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cornercap Investment Counsel's AMED Position: Q3 2019 in Review

Cornercap Investment Counsel sold out of Amedisys (AMED) in Q3 2019, closing a stake of 9,240 shares — an estimated $1.12M sold.

Cornercap Investment Counsel first reported a position in AMED in Q4 2018 and held it in 3 quarters. The position peaked at $1.15M in Q1 2019. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Cornercap Investment Counsel reported no remaining Amedisys position as of Q3 2019 after selling out during the quarter.
  • Cornercap Investment Counsel sold 9,240 Amedisys shares in Q3 2019, an estimated $1.12M.
  • Cornercap Investment Counsel first reported a position in Amedisys in Q4 2018 and held it in 3 quarters.
  • Cornercap Investment Counsel's Amedisys position peaked at $1.15M in Q1 2019.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Cornercap Investment Counsel's 13F filing for Q3 2019, filed 14 Nov 2019.